Letter: `Lifestyle' drugs
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Letter:
`Lifestyle' drugs
Sir: Your editorial "Who should pay for the `lifestyle' pills?" (9 October) contains important misconceptions. Drugs such as paroxetine do not immediately produce benefit in social anxiety disorder. The effect builds up over a period of weeks or months, quite different from the "quick fix" treatments such as tranquillisers, alcohol or even Coca-Cola.
You label paroxetine as a "lifestyle" drug. I take that to mean drugs which have no real medical utility but simply improve the way people feel about themselves or about life. A vast amount of evidence reveals social anxiety disorder to be a pervasive and debilitating condition that disrupts all aspects of sufferers' existence over years, even decades. I think you should not trivialise sufferers by equating the only proven effective treatment with a soft drink.
The editorial does address an important issue: what is the purpose of the NHS? One of its major roles must be to reduce suffering, and I can provide with you many testimonies from patients who have suffered enormously from their severe social anxiety and who would find it very difficult to fund treatment privately were your new-look NHS to view anxiety disorders as being outside its remit. I hope you weren't suggesting that other chronic illnesses that do not respond to emergency treatment - such as arthritis, diabetes and asthma - would also have to be paid for privately?
Professor DAVID NUTT
School of Medical Sciences
University of Bristol
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments